Clinical features of cyst infection and hemorrhage in ADPKD: New diagnostic criteria

Clinical and Experimental Nephrology

Volumn 16, Issue 6, 2012, Pages 892-902

  Suwabe, Tatsuya ^a   Ubara, Yoshifumi ^a,b   Sumida, Keiichi ^a   Hayami, Noriko ^a   Hiramatsu, Rikako ^a   Yamanouchi, Masayuki ^a   Hasegawa, Eiko ^a   Hoshino, Junichi ^a   Sawa, Naoki ^a   Saitoh, Satoshi ^a   Okuda, Itsuko ^a   Takaichi, Kenmei ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Autosomal dominant polycystic kidney disease (ADPKD); Clinical features; Cyst hemorrhage; Cyst infection; Diagnostic criteria

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL PAIN; ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; BODY TEMPERATURE MEASUREMENT; CITROBACTER FREUNDII; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYST WALL THICKENING; DIFFUSION WEIGHTED IMAGING; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; FLUID FLUID LEVEL; GAS FORMATION; HUMAN; IMAGE ANALYSIS; KIDNEY CYST HEMORRHAGE; KIDNEY CYST INFECTION; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERITIDIS; SYNDROME DELINEATION; UROGENITAL SYSTEM PARAMETERS;

ABDOMINAL PAIN; ADULT; AGED; BODY TEMPERATURE; C-REACTIVE PROTEIN; CYSTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMORRHAGE; HUMANS; KIDNEY; LEUKOCYTE COUNT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876290987     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0650-2     Document Type: Article

References (24)

1. Torres VE. Polycystic kidney disease autosomal-dominant and recessive forms. In: Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 896-904.
2. Fick GM, Johnson AM, Hammomd WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995;5:2048-56.
3. Peter CH, Vicente ET. Autosomal dominant polycystic kidney disease. Gene reviews. Bethesda: National Institutes of Health; 2009.
4. Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, et al. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Prac. 2009;112:c157-63.
5. Elzinga LW, Bennett WM. Miscellaneous renal and systemic complications of autosomal dominant polycystic kidney disease including infection. In: Watson ML, Torres VE, editors. Polycystic kidney disease. Northants: Oxford Medical; 1996. p. 483-99.
6. Levine E, Grantham JJ. The role of computed tomography in the evaluation of adult polycystic kidney disease. Am J Kidney Dis. 1981;1:99-105.
7. Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987;82:714-8.
8. Amesur P, Castronuovo JJ, Chandramouly B. Infected cyst localization with gallium SPECT imaging in polycystic kidney disease. Clin Nucl Med. 1988;13:35-7.
9. Bleeker-Rovers CP, de Sevaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2003;41:E18-21.
10. Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4:1183-9.
11. Laffon E, Cazeau AL, Monet A, de Clermont H, Fernandez Z, Marthan R et al. The effect of renal failure on 18F-FDG uptake: a theoretic assessment. J Nucl Med Technol 2008;36(4):200-2.
12. Ichioka K, Saito R, Matsui Y, Terai A. Diffusion-weighted magnetic resonance imaging of infected renal cysts in a patient with polycystic kidney disease. Urology. 2007;70(6):1219.
13. Katano K, Kakuchi Y, Nakashima A, Takahashi S, Kawano M. Efficacy of diffusion-weighted magnetic resonance imaging in detecting infected cysts in a case of polycystic kidney disease. Clin Nephrol. 2011;75:S24-6.
14. Verswijvel G, Vandecaveye V, Gelin G, Vandevenne J, Grieten M, Horvath M, et al. Diffusion-weighted MR imaging in the evaluation of renal infection: preliminary results. JBR-BTR. 2002;85(2):100-3.
15. Carragee E, Eugene J. The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine. 1997;22(7):780-5.
16. Ryan A, McCook B, Sholosh B, Pryma DA, Jablonowski E, Fuhrman C, et al. Acute intramural hematoma of the aorta as a cause of positive FDG PET/CT. Clin Nucl Med. 2007;32:729-31.
17. Repko BM, Tulchinsky M. Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET/CT. Clin Nucl Med. 2008;33:651-3.
18. Jouret F, Lhommel R, Beguin C, Devuyst O, Pirson Y, Hassoun Z, et al. Positron-emission computed tomoghraphy in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6:1644-50.
19. Bae KT, Grantham JJ. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010;6:96-106.
20. Kanaan N, Goffin E, Pirson Y, Devuyst O, Hassoun Z. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2010;55:916-22.
21. Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010;38:2229-41.
22. Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med. 2011;39:1792-9.
23. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171:1322-31.
24. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7:210-7.